Researchers in the NCI-designated Dan L Duncan Cancer Center at Baylor College of Medicine have been awarded an additional $9.9 million in grant funding from the Cancer Prevention and Research Institute of Texas.
The newest wave of funding brings Baylor’s total funding from the state cancer program to more than $130 million.
Baylor received $5.9 million for three early translational research grants – the highest amount awarded to an institution in the state in that category -- and $4 million in grants to help recruit promising first-time, tenure-track faculty members.
The individual awards included:
Early Translational Research
- Dr. Debananda Pati, professor of pediatrics – oncology at Baylor and a member of the Texas Children’s Cancer Center, for a $2 million grant project titled “Novel Separase Inhibitors to Treat Refractory Breast Cancer.”
- Dr. David Tweardy, professor of medicine – infectious diseases, for a $1,999,569 grant project titled “Oral Stat3 Inhibitor as Targeted Treatment for Triple-negative Breast Cancer.”
- Dr. Leonid Metelitsa, associate professor of pediatrics – oncology at Baylor and a member of the Texas Children’s Cancer Center, for a $1,928,220 grant project titled “NKT Cell Platform for Cancer Immunotherapy.”
Recruitment of First-Time, Tenure-Track Faculty Members
- A $2 million grant to help recruit Dr. Xi Chen, currently a post-doctoral associate at Weill Cornell Medical College, to Baylor.
- A $2 million grant to help recruit Dr. Melanie Samuel, currently a post-doctoral fellow at Harvard University, to Baylor.
CPRIT awarded a total of $65 million for 20 grants for product development, prevention, translational and recruitment programs.